From Feasibility to First Patient In: How to Streamline Study Start-Up

About the Webinar

Clinical trial delays are often assumed to occur during study conduct, but in reality, many originate much earlier, during study start-up. This webinar explores how early decisions made during feasibility and country selection can significantly influence timelines, introducing risks before the first patient is even screened.

Drawing on real-world experience, this session will demonstrate how shifting from a siloed, task-based approach to a fully integrated start-up strategy can improve predictability, strengthen execution, and accelerate time to First Patient In (FPI) without compromising quality.

Attendees will gain practical insights into aligning strategy with operational execution, embedding local expertise, and proactively managing risks across the start-up lifecycle.

What You’ll Learn

• How to transform study start-up from a linear, task driven, and siloed process into an integrated, cross-functional strategy.
• The key operational levers that drive faster, more predictable timelines from feasibility to FPI.
• How to incorporate local expertise, realistic country strategies, and proactive risk management into early study planning and decision-making.

Unable to join? Register and you will receive the recording after the live session.